Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I V Alekseenko

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Doklady. Biochemistry and Biophysics|September 20, 2011
Bicistronic vector for combined expression of the HSVtk killer gene and cytokine GM-CSF gene in cancer cellsI V Alekseenko, E P Kopantzev, T V Vinogradova, et al.
Doklady. Biochemistry and Biophysics|November 7, 2016
Expression of the FAP gene in non-fibroblast human cell lines. Development of cancer-associated fibroblast modelsD V Tyulkina, V V Pleshkan, I V Alekseenko, et al.
Molekuliarnaia Biologiia|December 30, 2015
[ Super-enhancers. Are they regulators of regulatory genes of development and cancer?]D A Didych, D V Tyulkina, V V Pleshkan, et al.
Acta Naturae|June 1, 2012
Promoters with cancer cell-specific activity for melanoma gene therapyV V Pleshkan, I V Alekseenko, M V Zinovyeva, et al.
Bioorganicheskaia Khimiia|February 21, 2015
[Cytotoxicity of cytosine deaminase and herpes simplex virus thymidine kinase genes in melanoma cells is independent on promoter strength]I V Alekseenko, D V Kuz'min, V V Pleshkan, et al.
Molekuliarnaia Genetika, Mikrobiologiia I Virusologiia|May 20, 2016
[ADULT STEM CELLS AND CELLS OF MALIGNANT ORIGIN. PART II]E D Sverdlov, V V Pleshkan, I V Alekseenko, et al.
Doklady. Biochemistry and Biophysics|July 16, 2018
A Universal Tumor-Specific Promoter for Cancer Gene TherapyI V Alekseenko, V V Pleshkan, A V Sass, et al.
Molekuliarnaia Genetika, Mikrobiologiia I Virusologiia|December 16, 2015
[ADULT STEM CELLS AND CELLS OF MALIGNANT ORIGIN. PART I]E D Sverdlov, V V Pleshkan, I V Alekseenko, et al.
Molekuliarnaia Genetika, Mikrobiologiia I Virusologiia|November 2, 2018
[FIBROBLAST ACTIVATION PROTEIN (FAP) AS A POSSIBLE TARGET OF THE ANTITUMOR STRATEGY.]V V Pleshkan, I V Alekseenko, D V Tyulkina, et al.
Molekuliarnaia Biologiia|January 9, 2017
[The cause of cancer mutations: Improvable bad life or inevitable stochastic replication errors?]I V Alekseenko, A I Kuzmich, V V Pleshkan, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Doklady. Biochemistry and Biophysics|September 20, 2011
Bicistronic vector for combined expression of the HSVtk killer gene and cytokine GM-CSF gene in cancer cellsI V Alekseenko, E P Kopantzev, T V Vinogradova, et al.
Doklady. Biochemistry and Biophysics|November 7, 2016
Expression of the FAP gene in non-fibroblast human cell lines. Development of cancer-associated fibroblast modelsD V Tyulkina, V V Pleshkan, I V Alekseenko, et al.
Molekuliarnaia Biologiia|December 30, 2015
[ Super-enhancers. Are they regulators of regulatory genes of development and cancer?]D A Didych, D V Tyulkina, V V Pleshkan, et al.
Acta Naturae|June 1, 2012
Promoters with cancer cell-specific activity for melanoma gene therapyV V Pleshkan, I V Alekseenko, M V Zinovyeva, et al.
Bioorganicheskaia Khimiia|February 21, 2015
[Cytotoxicity of cytosine deaminase and herpes simplex virus thymidine kinase genes in melanoma cells is independent on promoter strength]I V Alekseenko, D V Kuz'min, V V Pleshkan, et al.
Molekuliarnaia Genetika, Mikrobiologiia I Virusologiia|May 20, 2016
[ADULT STEM CELLS AND CELLS OF MALIGNANT ORIGIN. PART II]E D Sverdlov, V V Pleshkan, I V Alekseenko, et al.
Doklady. Biochemistry and Biophysics|July 16, 2018
A Universal Tumor-Specific Promoter for Cancer Gene TherapyI V Alekseenko, V V Pleshkan, A V Sass, et al.
Molekuliarnaia Genetika, Mikrobiologiia I Virusologiia|December 16, 2015
[ADULT STEM CELLS AND CELLS OF MALIGNANT ORIGIN. PART I]E D Sverdlov, V V Pleshkan, I V Alekseenko, et al.
Molekuliarnaia Genetika, Mikrobiologiia I Virusologiia|November 2, 2018
[FIBROBLAST ACTIVATION PROTEIN (FAP) AS A POSSIBLE TARGET OF THE ANTITUMOR STRATEGY.]V V Pleshkan, I V Alekseenko, D V Tyulkina, et al.
Molekuliarnaia Biologiia|January 9, 2017
[The cause of cancer mutations: Improvable bad life or inevitable stochastic replication errors?]I V Alekseenko, A I Kuzmich, V V Pleshkan, et al.
Pageof 2